We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
278 hedge funds and large institutions have $2.74B invested in Ginkgo Bioworks in 2022 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 101 increasing their positions, 55 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
84% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 55
82% more call options, than puts
Call options by funds: $35.3M | Put options by funds: $19.4M
55% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 38
42% more capital invested
Capital invested by funds: $1.93B → $2.74B (+$810M)
7% more funds holding
Funds holding: 260 → 278 (+18)
0.04% more ownership
Funds ownership: 1.8% → 1.84% (+0.04%)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
278
Holders Change
+18
Holders Change %
+6.92%
% of All Funds
4.79%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
59
Increased
101
Reduced
55
Closed
38
Calls
$35.3M
Puts
$19.4M
Net Calls
+$15.9M
Net Calls Change
+$12.3M
Top Buyers
Top Sellers
| 1 |
GA
General Atlantic
New York
|
-$111M |
| 2 |
SIG
Senator Investment Group
New York
|
-$22.9M |
| 3 |
Coatue Management
New York
|
-$18.9M |
| 4 |
Goldman Sachs
New York
|
-$9.4M |
| 5 |
Millennium Management
New York
|
-$8.79M |
